PAA 8.11% 20.0¢ pharmaust limited

Ann: PharmAust Initiates Combination Therapy Evaluations in Dogs, page-2

  1. 2,667 Posts.
    lightbulb Created with Sketch. 111
    This is the trial that I am most interested in! PPL-1 used with existing chemotherapy is our best chance at success IMO, if it can demonstrate added benefits with no added toxicity then we have a serious product.

    Great to see 2 dogs have already started and are currently being monitored for results, shouldn't be too long until we hear results from these!

    Management keeps ticking boxes.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.015(8.11%)
Mkt cap ! $89.00M
Open High Low Value Volume
19.0¢ 20.5¢ 18.8¢ $311.3K 1.576M

Buyers (Bids)

No. Vol. Price($)
1 100000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 388155 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.